Search

131I has been widely used in nuclear medicine for many years, particularly in the form of iodide for the diagnosis and therapy of thyroid cancer and other thyroid diseases. Manual dispensing of radioiodine-based radiopharmaceuticals results in potentially significant radiation doses to the hands of nuclear medicine personnel performing this task. This article reports the results of thermoluminescent dosemeter-based measurement of radiation doses at various points on the hands of personnel dispensing radioiodine radiopharmaceuticals. [ABSTRACT FROM AUTHOR]

The production of 18F-FDG is a multi-stage process, which includes not only obtaining the marker and labelling the radiopharmaceutical but also carrying out the quality control of the obtained compound. The staff can be exposed to ionizing radiation at any stage of production. This article presents the results of hands exposure of staff members employed in a facility, where 18F-FDG is produced and injected into patients. High-sensitivity thermoluminescent detectors (MCP-N) were used for measurements. The measurements were conducted with regard to the occupational structure the employees and the performed procedures. The obtained results showed that the highest risk of radiation exposure for personnel was associated with the quality control of the radiopharmaceutical. The daily doses registered by MCP-N detectors on fingertips reached 4.5 mSv, which may result in exceeding the annual radiation limit of 500 mSv., (© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)

The main aim of this study was to highlight the problems of personnel exposure when administering (153)Sm-labelled ethylene diamine tetramethylene phosphonate-Quadramet(®) to patients and especially to evaluate hand exposure of the personnel. The exposure levels of patients' families and the people who takes care of the patients treated by Quadramet(®) were also estimated. Thermoluminescent detectors were used to measure the doses. The doses received during the injection of the Quadramet(®) by the nursing staff have been determined at the level of 1/150 dose limit for the skin. Exposure of members of the patient's family staying 1.5 m away from the patient being treated with Quadramet(®) has been estimated to be 0.40 mGy., (© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)

The specific nature of work in nuclear medicine departments involves the use of isotopes and handling procedures, which contribute to the considerable value of an equivalent dose received, in particular, by the fingertips. Standard nuclear medicine department uses ring dosemeters placed usually at the base of the middle finger. The main aim of the study was to find out whether a relationship exists between the doses recorded by thermoluminescent detectors placed at various locations on the radiopharmacists' hands and the doses recorded by the ring detectors, and to determine the character of that relationship. The correction factor represents a correction value to be used to calculate the doses which might be received by locations on the hand from the dose recorded by the ring dosemeter. The dose recorded by the ring dosemeter is on the average five times lower than that received by the fingertips of thumb, index and middle fingers.